The Responses of Biobanks to COVID-19

Biopreserv Biobank. 2020 Dec;18(6):483-491. doi: 10.1089/bio.2020.29074.mkh. Epub 2020 Aug 31.

Marianne K Henderson¹, Zisis Kozlakidis², Jajah Fachiroh³, Beatrice Wiafe Addai^{4

5}, Xun Xu⁶, Sameera Ezzat^{7

8}, Heidi Wagner⁹, Márcia M C Marques^{10

11}, Birenda K Yadav¹²

¹ National Cancer Institute, NIH, DHHS, Bethesda, Maryland, USA.
² International Agency for Research on Cancer, World Health Organization, Lyon, France.
³ Biobank Development Team/Department of Histology and Cell Biology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
⁴ Peace and Love Hospitals, Kumasi, Ghana.
⁵ Peace and Love Hospitals, Accra, Ghana.
⁶ BGI Research Institute of Life Sciences, Shenzhen, China.
⁷ National Liver Institute, Menoufia University, Al Minufiyah, Egypt.
⁸ Shefaa El Orman Oncology Hospital, Luxor, Egypt.
⁹ UHN Biospecimen Services, Toronto, Canada.
¹⁰ Barretos Cancer Hospital, Barretos, Brazil.
¹¹ Barretos School of Health Sciences, Dr. Paulo Prata-FACISB, Barretos, Brazil.
¹² National Liver Disease Biobank, Institute of Liver and Biliary Sciences, New Delhi, India.

No abstract available

Keywords: COVID-19; biobank; pandemic response.

MeSH terms